Daito PharmaceuticalLtd Dividends and Buybacks
Dividend criteria checks 5/6
Daito PharmaceuticalLtd is a dividend paying company with a current yield of 2.94% that is well covered by earnings. Next payment date is on 5th August, 2026 with an ex-dividend date of 28th May, 2026.
Key information
2.9%
Dividend yield
3.1%
Buyback Yield
| Total Shareholder Yield | 6.0% |
| Future Dividend Yield | 3.2% |
| Dividend Growth | 10.1% |
| Next dividend pay date | 05 Aug 26 |
| Ex dividend date | 28 May 26 |
| Dividend per share | n/a |
| Payout ratio | 50% |
Recent dividend and buyback updates
Daito PharmaceuticalLtd (TSE:4577) Is Due To Pay A Dividend Of ¥20.00
Feb 03
Daito PharmaceuticalLtd (TSE:4577) Is Due To Pay A Dividend Of ¥20.00
Nov 02Daito PharmaceuticalLtd (TSE:4577) Has Announced A Dividend Of ¥20.00
Oct 13Recent updates
Daito PharmaceuticalLtd (TSE:4577) Is Due To Pay A Dividend Of ¥20.00
Feb 03Daito PharmaceuticalLtd (TSE:4577) Is Due To Pay A Dividend Of ¥20.00
Nov 02Daito PharmaceuticalLtd (TSE:4577) Has Announced A Dividend Of ¥20.00
Oct 13Why Daito PharmaceuticalLtd's (TSE:4577) Shaky Earnings Are Just The Beginning Of Its Problems
Jul 20Daito PharmaceuticalLtd (TSE:4577) Has Announced A Dividend Of ¥35.00
May 27Daito PharmaceuticalLtd (TSE:4577) Is Due To Pay A Dividend Of ¥35.00
Mar 15Daito PharmaceuticalLtd (TSE:4577) Is Due To Pay A Dividend Of ¥35.00
Feb 04Daito PharmaceuticalLtd's (TSE:4577) Problems Go Beyond Weak Profit
Jan 18Daito PharmaceuticalLtd's (TSE:4577) Weak Earnings May Only Reveal A Part Of The Whole Picture
Jul 19Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 4577's dividends per share have been stable in the past 10 years.
Growing Dividend: 4577's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Daito PharmaceuticalLtd Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (4577) | 2.9% |
| Market Bottom 25% (JP) | 1.7% |
| Market Top 25% (JP) | 3.4% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast (4577) (up to 3 years) | 3.2% |
Notable Dividend: 4577's dividend (2.94%) is higher than the bottom 25% of dividend payers in the JP market (1.68%).
High Dividend: 4577's dividend (2.94%) is low compared to the top 25% of dividend payers in the JP market (3.42%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (50.5%), 4577's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (24.4%), 4577's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/06 13:22 |
| End of Day Share Price | 2026/02/06 00:00 |
| Earnings | 2025/11/30 |
| Annual Earnings | 2025/05/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Daito Pharmaceutical Co.,Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yukichi Okabe | Okasan Securities Co. Ltd. |
| Takashi Akahane | Tokai Tokyo Intelligence Laboratory Co., Ltd. |
| Masao Yoshida | Tokai Tokyo Intelligence Laboratory Co., Ltd. |